KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Asset Utilization Ratio (2016 - 2025)

Regeneron Pharmaceuticals (REGN) has 14 years of Asset Utilization Ratio data on record, last reported at 0.27 in Q3 2025.

  • For Q3 2025, Asset Utilization Ratio changed N/A year-over-year to 0.27; the TTM value through Sep 2025 reached 0.27, changed N/A, while the annual FY2024 figure was 0.4, 4.79% down from the prior year.
  • Asset Utilization Ratio reached 0.27 in Q3 2025 per REGN's latest filing, down from 0.27 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.31 in Q3 2022 and bottomed at 0.01 in Q4 2022.
  • Average Asset Utilization Ratio over 4 years is 0.19, with a median of 0.19 recorded in 2023.
  • The widest YoY moves for Asset Utilization Ratio: up 2728.59% in 2023, down 32.85% in 2023.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.01 in 2022, then soared by 2728.59% to 0.2 in 2023, then decreased by 8.52% to 0.18 in 2024, then soared by 46.53% to 0.27 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.27 in Q3 2025, 0.27 in Q2 2025, and 0.18 in Q1 2025.